Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
Widespread CPR and AED training can be done for minimal cost and instruction time with this method
Researchers discuss the best target temperature, 33 C or 36 C, for cardiac arrest patients in the post-arrest care phase
A bartender recently trained as EMT, a nurse and two medics intervened to save a man who went into cardiac arrest while at a restaurant
The 18-year-old later told police he had taken a mix of MDMA and cocaine
Newly diagnosed with Wolff-Parkinson-White syndrome, he made the video while recovering and awaiting heart surgery
Chest compression performance was measured six months after training
Resuscitation Outcomes Consortium study of out-of-hospital cardiac arrest found little difference in neurologically intact survival
The Attorney General’s Office anticipates the first wave of the grant program to fund the distribution of at least 1,000 naloxone kits to first responders
Survivors in Wake County EMS study had a witnessed arrest with a shockable rhythm and prehospital ROSC
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.